Le Lézard
Classified in: Health, Business
Subjects: BUSINESS CONTRACTS, HEALTH, SHAREHOLDER RIGHTS PLANS, MISCELLANEOUS, MISCELLANEOUS

John Phillips Joins Pharmaceutics International Inc. (Pii) as Vice President of Sales


Hunt Valley, MD, March 14, 2023 (GLOBE NEWSWIRE) -- Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) is proud to announce that John Phillips has joined the company as Vice President of Sales. Mr. Phillips brings a wealth of almost 30 years of life sciences and pharmaceutical executive business leadership to his new role at Pii.

Before joining Pii, he served on the executive management team of Bio-Duro as Vice President of Business Development. Mr. Phillips played a key role in engaging with customers to evaluate their business needs. He also spent several years working at Patheon and Thermo Fisher as the Senior Director of Business Development Americas-East, where he made addressing customer requests central to his responsibilities. Additionally, he has held leadership positions at Sharp, Aptuit, and Micron Technologies, Inc. He received his Bachelor's degree from Widener University.

"Pii is fortunate to have Mr. Phillips join and lead our sales team," said John Fowler, president and CEO of Pii. "Throughout his career, he has proven to be an organizational leader and empowering mentor committed to driving customer excellence."

About Pii
Pharmaceutics International, Inc. (Pii) is a US-based contract development and manufacturing organization (CDMO) with a passion for solving problems. Pii's Hunt Valley, Maryland, campus includes 70 manufacturing suites with four integrated aseptic filling lines. We offer contract analytical development and support formulation and manufacturing of oral solid dosage forms. Our professionals have extensive experience with small and large molecule compounds, developing and manufacturing complex parenteral drugs, extended-release formulations, non-aqueous injectable drug products, and lyophilization. Pii is proudly the first to market with THC soft gels, highlighting our experience with FDA-approved cannabis products. Learn more at www.pharm-int.com.

###



These press releases may also interest you

at 12:35
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and...

at 12:33
Assar Gabrielsson was one of the founders of Volvo. In accordance with his wishes, a fund was established for clinical research of cancer diseases. The fund has existed since 1962. It primarily supports research projects that are considered promising...

at 12:30
Following a competitive national search, the University of Colorado Anschutz Medical Campus is proud to announce that John H. Sampson, MD, PhD, MHSc, MBA, has been selected as the University of Colorado School of Medicine Dean and Vice Chancellor for...

at 12:24
Restored Smiles is set to shine at the California Dental Association (CDA) Conference 2024, showcasing foundational dental courses and offering exciting opportunities for dentists to win prizes and explore the next steps in their training journey....

at 12:23
Infection preventionists are reaching out to policymakers for help with the regulatory process around the current convoluted medical device cleaning instructions, known as instructions for use or IFUs, with which they must comply and are calling for...

at 12:22
Academy of General Dentistry (AGD) member and Alabama general dentist Gordon R. Isbell III, DMD, MAGD, testified before the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) today, and discussed access to and issues facing the...



News published on and distributed by: